NQO1
protein-codingNAD(P)H quinone dehydrogenase 1
Gene summary
This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
- NMOR1
- DIA4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~19.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NQO1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000903.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 129 | 129 | ||||
| missense | 1 | 131 | 5 | 137 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 2 | 134 | 134 | 0 | 270 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000894.1 | 6 | MANE Select | |
| Ensembl | ENSP00000319788.5 | 6 | MANE Select | |
| RefSeq | NP_001020604.1 | 5 | Standard | |
| RefSeq | NP_001020605.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human)
- Doxorubicin Pathway (Cancer Cell), Pharmacodynamics
- Hepatocellular carcinoma - Homo sapiens (human)
- Fluid shear stress and atherosclerosis - Homo sapiens (human)
- Doxorubicin Pathway, Pharmacokinetics
Biological Process
- regulation of cellular amino acid metabolic process
- xenobiotic metabolic process
- nitric oxide biosynthetic process
- synaptic transmission, cholinergic
- aging
Molecular Function
- RNA binding
- NAD(P)H dehydrogenase (quinone) activity
- cytochrome-b5 reductase activity, acting on NAD(P)H
- superoxide dismutase activity
- protein binding
Cellular Component
- cytoplasm
- cytosol
- dendrite
- neuronal cell body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000320623
- Coding exons
- 6
- Length
- 19956
- Individuals with no LoFs
- 124869
- Homozygous LoFs
- 12
- Heterozygous LoFs
- 866
- Defined
- 125747
- p
- 0.00350
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.28 | 106 | 150 | 0.705 | 0.00000768 | 1803 |
| Missense (PolyPhen) | 35 | 58.312 | 0.60022 | 687 | ||
| Synonymous | -0.0322 | 58 | 57.7 | 1.01 | 0.00000338 | 516 |
| Loss of Function | 0.113 | 14 | 14.5 | 0.968 | 7.88e-7 | 157 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.037 | 0.037 | notable |
| Latino/Admixed American | 0.0042 | 0.0042 | notable |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00074 | 0.00074 | rare |
| European (Non-Finnish) | 0.00081 | 0.00081 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0.0031 | 0.0031 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.;
Recessive Scores
- pRec
- 0.755
Intolerance Scores
- LoFtool
- 0.989
- RVIS EVS
- 0.55
- RVIS percentile EVS
- 81.38
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.989
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |